Evidence map›Paper›PMID 41028324›Full record

ReviewHandbook of experimental pharmacology2026

S-Nitrosylation of GPCR Regulatory Machinery as a Mechanism to Bias Signaling.

Mingda Chen, Zachary W Grimmett, Richard T Premont, Jonathan S Stamler

Abstract readReview
PubMed Publisher
In one paragraph

Review in Handbook of experimental pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mingda ChenInstitute for Transformative Molecular Medicine and Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Zachary W GrimmettInstitute for Transformative Molecular Medicine and Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Richard T PremontInstitute for Transformative Molecular Medicine and Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Jonathan S StamlerInstitute for Transformative Molecular Medicine and Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA. jss156@case.edu.

Funding

Project 3 - Personalized cystic fibrosis treatment strategies with synergistic therapies Identified in vitro.P01HL128192 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN · 2016 to 2020
$12.2M
S-nitrosylation signaling in asthmaP01HL158507 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN · 2021 to 2025
$12.0M
Role of S-Nitrosylation on Beta-Adrenergic Signaling in Cardiac Injury and RepairR01HL157151 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KOCH, WALTER J., STAMLER, JONATHAN S. · 2021 to 2024
$2.8M
NHLBI NIH HHS P01 HL128192NHLBI NIH HHS P01 HL158507NHLBI NIH HHS R01 HL157151
6 · The paper itself

Abstract

Upon stimulation by endogenous ligands, G protein-coupled receptors (GPCRs) activate downstream signaling pathways through multiple mechanisms, including G protein subtypes, β-arrestins, and receptor-specific partners. Synthetic ligands may activate only a subset of these pathways, resulting in functional selectivity or signaling bias. Since not all signaling outputs are therapeutically desirable, there is pharmaceutical interest in exploiting biased signaling. Although much effort is focused on designing ligands to induce receptor conformations that result in signal bias, it is also true that cellular systems adapt dynamically in ways that tune receptor signaling, termed system bias. In this chapter, we provide evidence that posttranslational modification of receptor machinery by S-nitrosylation is an important regulator of system bias in GPCR signaling. S-nitrosylation has been reported to affect the function of multiple classes of GPCR signaling pathway components, including receptors, G proteins, G protein-coupled receptor kinases, β-arrestins, and others. Further, untargeted proteomic studies of S-nitrosylated proteins have identified over 60 GPCRs, most heterotrimeric G proteins, and numerous GPCR signaling components, hinting at a class effect and unifying mechanism to bias the functional repertoires of GPCRs in vivo. Thus, protein S-nitrosylation provides prototypic examples for how post-translational regulatory mechanisms bias GPCRs endogenously.

Indexed as

Nitric OxideProtein Processing, Post-TranslationalReceptors, G-Protein-CoupledSignal TransductionAnimalsHumansLigandsLigandsNitric OxideReceptors, G-Protein-CoupledBiased signalingFunctional selectivityG protein-coupled receptorS-nitrosothiolS-nitrosylationSystemic bias

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.